News

Kinapse to present at Futureceuticals event at Royal College of Surgeons, London.

Thursday, September 15th, 2011

London, UK
Kinapse is pleased to announce its support of Talentmark’s 40th Anniversary celebrations at a ‘Futureceuticals’ event being held today at the Royal College of Surgeons in London.
Andy Black, Kinapse Chief Executive Officer, and Fellow of the Royal College of Surgeons, will be attending the evening and delivering a presentation on “Ideas about the future [...]

Read more »

Kinapse selected by European Medicines Agency to provide EudraVigilance data management services

Monday, October 25th, 2010

London, UK
Kinapse announced today that it has been selected through a European open procurement procedure to provide data management services to the European Medicines Agency (EMA). The estimated contract value is € 6,500,000.
The scope of the agreed framework contract covers detection and management of duplicate Individual Case Safety Reports (ICSRs), manual recoding of medicinal [...]

Read more »

Chris Brinsmead joins the Board of Kinapse UK Ltd.

Monday, September 27th, 2010

London, UK
The Board of Directors of Kinapse Ltd. is delighted to announce that Chris Brinsmead has agreed to become a Non-Executive Director of Kinapse. Chris has had a long and distinguished career in the pharmaceutical industry, notably with Astra Zeneca where he was the President of their UK business. He has also recently [...]

Read more »

Andy Black reappointed as Kinapse Chief Executive

Monday, September 27th, 2010

London, UK
The Board of Directors of Kinapse Ltd. today announced that Andy Black has been appointed to succeed Shalabh Kumar as Chief Executive Officer, effective immediately.
Andy Black said “I am pleased and honoured to once again take on the Chief Executive role. My first priorities will be to ensure that Kinapse’s clients receive [...]

Read more »

Kinapse CEO stepping down

Friday, September 24th, 2010

London, UK
The Board of Directors of Kinapse Ltd. today announced that Co-founder Shalabh Kumar has stepped down as Chief Executive Officer, effective immediately. He will continue as a Shareholder and as a Non-executive Director on the Board of Kinapse Ltd.
Nick Edwards, Chairman of Kinapse Ltd., said, “I would like to thank Shalabh for his contributions [...]

Read more »

Kinapse to present at the 2009 Project & Portfolio Management in the Pharmaceutical Industry Conference in Vienna, Austria

Friday, September 18th, 2009

Kinapse to present at the 2009 Project & Portfolio Management in the Pharmaceutical Industry Conference in Vienna, Austria
London, UK (September 4th, 2009)
Kinapse are pleased to announce their role as collaborative partner and sponsor of the 5th Annual Project & Portfolio Management in the Pharmaceutical Industry Conference in Vienna, Austria on the 17th and 18th September [...]

Read more »

New Website and Logo launch

Sunday, August 23rd, 2009

Kinapse is pleased to announce the launch of its new logo and Website.  Kinapse has grown considerably since its conception and to reflect the larger client base  and our diversifying capabilities, we have developed a new logo and branding.  In order to provide customers with a more targeted service, we have split the company’s offerings into [...]

Read more »

Patient compliance is a major issue

Sunday, August 23rd, 2009

The pharmaceutical industry loses $177 billion annually as a result of poor patient compliance and adherence to medication.  With average non-compliance rates hovering around 50% the industry urgently needs to find ways of helping patients be more compliant. 
Although there is no simple answer, a combination of solutions, such as working with patient groups and using [...]

Read more »